Latest News for: Pharmaceutical sources

Edit

Germany Healthcare, Regulatory and Reimbursement Landscape Market Report- Global Industry Analysis 2021-2026

The Sentinel Newspaper 14 Jun 2021
Germany Healthcare, Regulatory and Reimbursement Landscape Market Report is an essential source of information on analysis of the healthcare, regulatory and reimbursement landscape in Germany ... Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets.
Edit

Aucta Pharma and Oakrum Pharma Announce Launch of Generic Version of JADENU(R) Sprinkle (Deferasirox Granules)

Maryville Daily Forum 14 Jun 2021
PISCATAWAY, N.J., June 14, 2021 /PRNewswire/ -- Aucta Pharmaceuticals, Inc ... Shoufeng Li, CEO of Aucta Pharmaceuticals stated, "We are excited to bring another Aucta Pharmaceuticals developed product to the U.S ... A few of these near-term launches are products developed by Aucta Pharmaceuticals."� ... SOURCE Aucta Pharmaceuticals, Inc.
Edit

Amylyx Pharmaceuticals Files New Drug Submission for AMX0035 for the Treatment of ALS in Canada

The Marshall News Messenger 14 Jun 2021
About Amylyx Pharmaceuticals. Amylyx Pharmaceuticals, Inc. is a pharmaceutical company working on developing a novel therapeutic for Amyotrophic Lateral Sclerosis (ALS), Alzheimer’s disease and other neurodegenerative diseases ... View source version on businesswire.com. ... HEALTH CLINICAL TRIALS RESEARCH PHARMACEUTICAL SCIENCE BIOTECHNOLOGY. SOURCE.
Edit

Aurinia Announces Addition of Dr. Brinda Balakrishnan to the Board of Directors

The Maryville Daily Times 14 Jun 2021
Aurinia Pharmaceuticals Inc ... Balakrishnan is Group Vice President, Corporate and Business Development of BioMarin Pharmaceutical Inc ... Brinda Balakrishnan, newly appointed Director to the Aurinia Pharmaceuticals Board ... View source version on businesswire.com.https.//www.businesswire.com/news/home/20210614005185/en/ ... SOURCE. Aurinia Pharmaceuticals Inc.
Edit

Telix Pharmaceuticals and Applied Radiology Launch TelixU Medical Education Platform Focused on Radiopharmaceutical Research

Hastings Tribune 14 Jun 2021
Telix Pharmaceuticals Limited (ASX ... “We are proud to support SNMMI and their endeavors to educate physicians and their membership,” says Colin Hayward, MBBS FFPM, Chief Medical Officer, Telix Pharmaceuticals ... About Telix Pharmaceuticals Limited ... View source version on businesswire.com.https.//www.businesswire.com/news/home/20210614005229/en/ ... SOURCE.
Edit

Global Pharmaceutical Anti-Counterfeiting Technologies Market Report, History and Forecast 2016-2027, Breakdown Data by Companies, Key ...

The Sentinel Newspaper 14 Jun 2021
Global Pharmaceutical Anti-Counterfeiting Technologies Market Report, History and Forecast 2016-2027, Breakdown Data by Companies, Key Regions, Types and Application. research report is the new statistical data source added by Oneup Business Insights ... Global Pharmaceutical Anti-Counterfeiting Technologies Market.
Edit

Ampio Pharmaceuticals to Present at the 2021 International Society for Pharmaceutical Engineers Annual Meeting and Expo

Daily Times Chronicle 14 Jun 2021
ENGLEWOOD, Colo., June 14, 2021 /PRNewswire/ -- Ampio Pharmaceuticals (NYSE American ... About Ampio Pharmaceuticals. Ampio Pharmaceuticals, Inc ... SOURCE Ampio Pharmaceuticals, Inc.
Edit

Forma Therapeutics Announces Appointment of Industry Veteran John E. Bishop, Ph.D., as Chief Technology Officer

The Marshall News Messenger 14 Jun 2021
John’s extensive expertise in small-molecule pharmaceuticals and proven track record as a leader will help to expedite drug development and commercialization at Forma, speeding us on our mission of transforming the lives of patients with rare hematologic diseases and cancers.” ... View source version on businesswire.com. ... SOURCE.
Edit

Jazz Pharmaceuticals and Leading Cancer Organizations Collaborate to Launch First and Only Digital Hub Focused ...

The Maryville Daily Times 14 Jun 2021
DUBLIN, June 14, 2021 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq ... hematology and oncology at Jazz Pharmaceuticals ... About Jazz Pharmaceuticals plc Jazz Pharmaceuticals plc (NASDAQ ... Vice President, Head, Investor Relations Jazz Pharmaceuticals plc investorinfo@jazzpharma.com Ireland, +353 1 634 3211 ... SOURCE Jazz Pharmaceuticals plc.
Edit

Expansion Therapeutics Names Mark Ledeboer, Ph.D., Senior Vice President of Drug Discovery

The Marshall News Messenger 14 Jun 2021
BOSTON--(BUSINESS WIRE)--Jun 14, 2021-- ... Ledeboer ... Ledeboer held various roles of increasing responsibility in drug discovery at Vertex Pharmaceuticals where he was a research fellow in Medicinal Chemistry. Dr ... View source version on businesswire.com. ... SCIENCE OTHER SCIENCE BIOTECHNOLOGY RESEARCH PHARMACEUTICAL HEALTH GENETICS CLINICAL TRIALS. SOURCE.
Edit

taiba Middle East FZ LLC Announces a Commercialization and Distribution Agreement With Insmed for ARIKAYCE® ...

The Marshall News Messenger 14 Jun 2021
taiba Middle East, a leading regional pharmaceutical company specializing in orphan and rare diseases in the region of Middle East/North Africa, announces that ... *Source.. View source version on businesswire.com. ... INFECTIOUS DISEASES PHARMACEUTICAL HEALTH MEDICAL SUPPLIES. SOURCE.
Edit

Dr. Paul Burton to Join Moderna as Chief Medical Officer

The Marshall News Messenger 14 Jun 2021
Paul’s extensive medical experience in the global pharmaceutical and biotech industry will be important to Moderna as we expand internationally and continue our journey as a commercial company,” said Stéphane Bancel, Chief Executive Officer of Moderna ... View source version on businesswire.com. ... INFECTIOUS DISEASES BIOTECHNOLOGY PHARMACEUTICAL HEALTH.
Edit

Global Antisense Oligonucleotide Therapeutics Pipeline Insight 2021 Report - ResearchAndMarkets.com

The Marshall News Messenger 14 Jun 2021
DUBLIN--(BUSINESS WIRE)--Jun 14, 2021--. The drug pipelines has been added to ResearchAndMarkets.com's offering ... It covers the pipeline drug profiles, including clinical and nonclinical stage products ... Report Highlights ... InDex Pharmaceuticals ... Phase III include, InDex Pharmaceuticals ... View source version on businesswire.com. ... HEALTH PHARMACEUTICAL. SOURCE.
Edit

Cyclo Therapeutics Announces Inclusion in the Russell 2000® Index

The Marshall News Messenger 14 Jun 2021
... products, success in attracting additional customers and profitable contracts, and regulatory risks associated with producing pharmaceutical grade and food products ... View source version on businesswire.com. ... BIOTECHNOLOGY HEALTH GENETICS PHARMACEUTICAL CLINICAL TRIALS. SOURCE.
Edit

TILT Biotherapeutics Submits IND for Phase I Trial of Immunotherapeutic TILT-123 in Ovarian Cancer

The Marshall News Messenger 14 Jun 2021
HELSINKI--(BUSINESS WIRE)--Jun 14, 2021-- ... The trial will include 15 to 30 patients and will be led by Dr ... Jyrki brings over 30 years of expertise in pharmaceuticals and life sciences from his positions held in Europe, USA and Japan ... -Ends- ... View source version on businesswire.com. ... BIOTECHNOLOGY HEALTH PHARMACEUTICAL CLINICAL TRIALS ONCOLOGY. SOURCE.
×